Your Messages Inbox
Your Article Summary
See Latest ArticlesBiovail Announces Dismissal of Securities Litigation
BioVail Corporation, 05/12/09
Biovail Corporation announced that, on May 2009, the United States District Court for the Southern District of New York issued a decision dismissing with prejudice a purported securities fraud lawsuit against Biovail and several of its present and former officers and directors. The complaint related to statements alleged to have been made by the Company and by certain officers in respect of Aplenzin during the product's U.S. regulatory approval process.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Watson Files FDA Application for Generic Rozerem
Watson Pharmaceuticals, 12/07/09
Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Apixaban In Europe
Bristol Myers-Squibb Company, 12/07/09
Non-safety-related voluntary recall of a limited portion of Daytrana (methylphenidate transdermal system) patches announced
Shire, 12/07/09
Article Search
Sponsor